Welcome to the Recombinant Antibody Network

Latest Publications

Synthetic antibodies targeting EphA2 induce diverse signaling-competent clusters with differential activation Journal Article
In: Protein Sci, vol. 34, no. 6, pp. e70145, 2025, ISSN: 1469-896X.

Molecular characterization of a synthetic neutralizing antibody targeting p67 of Theileria parva Journal Article
In: Protein Sci, vol. 34, no. 6, pp. e70153, 2025, ISSN: 1469-896X.

Locking CBL TKBD in its native conformation presents a novel therapeutic opportunity in mutant CBL-dependent leukemia Journal Article
In: Mol Ther, 2025, ISSN: 1525-0024.
Latest News
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco, the…
Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced a…
RAN to collaborate with Celgene on cancer therapeutics development
The RAN has recently signed a 3-year $25M agreement with the Celgene Corporation to develop next-generation,…